Journal
TRENDS IN PHARMACOLOGICAL SCIENCES
Volume 41, Issue 10, Pages 730-742Publisher
ELSEVIER SCIENCE LONDON
DOI: 10.1016/j.tips.2020.08.001
Keywords
-
Categories
Funding
- Breast Cancer Research Foundation
- Advanced Medical Research Foundation
- OFD/BTREC/CTREC Faculty Career Development Fellowship from Boston Children's Hospital
Ask authors/readers for more resources
Nanomedicine represents an important class of cancer therapy. Clinical translation of cancer nanomedicine has significantly reduced the toxicity and adverse consequences of standard-of-care chemotherapy. Recent advances in new cancer treatment modalities (e.g., gene and immune therapies) are profoundly changing the oncology landscape, bringing with them new requirements and challenges for next-generation cancer nanomedicines. We present an overview of cancer nanomedicines in four emerging oncology-associated fields: (i) gene therapy, (ii) immunotherapy, (iii) extracellular vesicle (EV) therapy, and (iv) machine learning-assisted therapy. We discuss the incorporation of nanomedicine into these emerging disciplines, present prominent examples, and evaluate their advantages and challenges. Finally, we discuss future opportunities for next-generation cancer nanomedicines.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available